Cryptoxanthin carotenoid interactions

The presence of other carotenoids can affect the absorption of carotenoids into intestinal mucosal cells, since carotenoids can compete for absorption or facilitate the absorption of another. Data on carotenoid interactions are not clear. Human studies show that /3-carotene decreases lutein absorption, while lutein has either no effect or a lowering effect on /3-carotene absorption. Although not confirmed in humans, the inhibitory effect of lutein on /3-carotene absorption might be partly attributed to the inhibition of the /3-carotene cleavage enzyme by lutein shown in rats. Beta-carotene also seemed to lower absorption of canthaxanthin, whereas canthaxanthin did not inhibit /3-carotene absorption. Studies showed that /3-carotene increased lycopene absorption, although lycopene had no effect on /3-carotene. Alpha-carotene and cryptoxanthin show high serum responses to dietary intake compared to lutein. In addition, cis isomers of lycopene seem to be more bioavailable than the -trans, and selective intestinal absorption of a)X-trans /3-carotene occurs, as well as conversion of the 9-cis isomer to sW-trans /3-carotene. It is clear, then, that selective absorption of carotenoids takes place into the intestinal mucosal cell. 

The lag-phase measurement at 234 nm of the development of conjugated dienes on copper-stimulated LDL oxidation is used to define the oxidation resistance of different LDL samples (Esterbauer et al., 1992). During the lag phase, the antioxidants in LDL (vitamin E, carotenoids, ubiquinol-10) are consumed in a distinct sequence with a-tocopherol as the first followed by 7-tocopherol, thereafter the carotenoids cryptoxanthin, lycopene and finally /3-carotene. a-Tocopherol is the most prominent antioxidant of LDL (6.4 1.8 mol/mol LDL), whereas the concentration of the others 7-tocopherol, /3-carotene, lycopene, cryptoxanthin, zea-xanthin, lutein and phytofluene is only 1/10 to 1/300 of a-tocopherol. Since the tocopherols reside in the outer layer of the LDL molecule, protecting the monolayer of phospholipids and the carotenoids are in the inner core protecting the cholesterylesters, and the progression of oxidation is likely to occur from the aqueous interface inwards, it seems reasonable to assign to a-tocopherol the rank of the front-line antioxidant. In vivo, the LDL will also interact with the plasma water-soluble antioxidants in the circulation, not in the artery wall, as mentioned above. 

Reversed-phase liquid chromatography shape-recognition processes are distinctly limited to describe the enhanced separation of geometric isomers or structurally related compounds that result primarily from the differences between molecular shapes rather than from additional interactions within the stationary-phase and/or silica support. For example, residual silanol activity of the base silica on nonend-capped polymeric Cis phases was found to enhance the separation of the polar carotenoids lutein and zeaxanthin [29]. In contrast, the separations of both the nonpolar carotenoid probes (a- and P-carotene and lycopene) and the SRM 869 column test mixture on endcapped and nonendcapped polymeric Cig phases exhibited no appreciable difference in retention. The nonpolar probes are subject to shape-selective interactions with the alkyl component of the stationary-phase (irrespective of endcapping), whereas the polar carotenoids containing hydroxyl moieties are subject to an additional level of retentive interactions via H-bonding with the surface silanols. Therefore, a direct comparison between the retention behavior of nonpolar and polar carotenoid solutes of similar shape and size that vary by the addition of polar substituents (e.g., dl-trans P-carotene vs. dll-trans P-cryptoxanthin) may not always be appropriate in the context of shape selectivity. 

From above results, it suggests that retinoids such as retinal (16), retinol (vitamin A, 18) and retinoic acid (20), and carotenoids such as P-carotene (2), P-cryptoxanthin (5) and lycopene (3) could regulate the expression of P,P-carotene 15,15 -monooxygenase using a transcriptional feedback mechanism through their interaction with the members of the retinoic acid (20) receptor (RAR) family (Figure 5) [11]. 

---